• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于生物信息学的 CDR 环分析揭示抗体多反应性的生化模式。

Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.

机构信息

Graduate Program in Biophysical Sciences, University of Chicago, Chicago, United States.

Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, United States.

出版信息

Elife. 2020 Nov 10;9:e61393. doi: 10.7554/eLife.61393.

DOI:10.7554/eLife.61393
PMID:33169668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7755423/
Abstract

Antibodies are critical components of adaptive immunity, binding with high affinity to pathogenic epitopes. Antibodies undergo rigorous selection to achieve this high affinity, yet some maintain an additional basal level of low affinity, broad reactivity to diverse epitopes, a phenomenon termed 'polyreactivity'. While polyreactivity has been observed in antibodies isolated from various immunological niches, the biophysical properties that allow for promiscuity in a protein selected for high-affinity binding to a single target remain unclear. Using a database of over 1000 polyreactive and non-polyreactive antibody sequences, we created a bioinformatic pipeline to isolate key determinants of polyreactivity. These determinants, which include an increase in inter-loop crosstalk and a propensity for a neutral binding surface, are sufficient to generate a classifier able to identify polyreactive antibodies with over 75% accuracy. The framework from which this classifier was built is generalizable, and represents a powerful, automated pipeline for future immune repertoire analysis.

摘要

抗体是适应性免疫的关键组成部分,能够与病原体表位高亲和力结合。抗体经过严格的选择以实现这种高亲和力,但有些抗体仍保持着额外的低亲和力基础水平,对多种表位具有广泛的反应性,这种现象被称为“多反应性”。虽然在从各种免疫部位分离的抗体中观察到了多反应性,但对于在选择用于与单一靶标高亲和力结合的蛋白质中允许混杂的生物物理特性仍不清楚。我们使用了一个包含 1000 多个多反应性和非多反应性抗体序列的数据库,创建了一个生物信息学管道来分离多反应性的关键决定因素。这些决定因素包括增加环间串扰和中性结合表面的倾向,足以产生一个能够以超过 75%的准确率识别多反应性抗体的分类器。构建这个分类器的框架是可推广的,代表了未来免疫受体库分析的一种强大的、自动化的管道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/fa1f47a928e2/elife-61393-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/7698690fec8a/elife-61393-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/45f7e4b0d7d2/elife-61393-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/4d4fb201a6d5/elife-61393-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/0f29a134c4cf/elife-61393-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/142c898d062b/elife-61393-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/a71b7ff55f33/elife-61393-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/0419e2494603/elife-61393-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/d35028278209/elife-61393-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/889f0acf60ee/elife-61393-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/8771ae8c283a/elife-61393-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/b7f595f9bc1f/elife-61393-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/934de75d49aa/elife-61393-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/c0e19af6e666/elife-61393-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/07571f182f4a/elife-61393-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/15ff2201bfc3/elife-61393-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/9279200fe2b3/elife-61393-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/7b5ce1da241f/elife-61393-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/f2d841b05d96/elife-61393-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/cca1167b3b10/elife-61393-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/fa1f47a928e2/elife-61393-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/7698690fec8a/elife-61393-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/45f7e4b0d7d2/elife-61393-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/4d4fb201a6d5/elife-61393-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/0f29a134c4cf/elife-61393-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/142c898d062b/elife-61393-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/a71b7ff55f33/elife-61393-fig1-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/0419e2494603/elife-61393-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/d35028278209/elife-61393-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/889f0acf60ee/elife-61393-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/8771ae8c283a/elife-61393-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/b7f595f9bc1f/elife-61393-fig3-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/934de75d49aa/elife-61393-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/c0e19af6e666/elife-61393-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/07571f182f4a/elife-61393-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/15ff2201bfc3/elife-61393-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/9279200fe2b3/elife-61393-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/7b5ce1da241f/elife-61393-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/f2d841b05d96/elife-61393-fig5-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/cca1167b3b10/elife-61393-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/793e/7755423/fa1f47a928e2/elife-61393-resp-fig1.jpg

相似文献

1
Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.通过基于生物信息学的 CDR 环分析揭示抗体多反应性的生化模式。
Elife. 2020 Nov 10;9:e61393. doi: 10.7554/eLife.61393.
2
Biochemical and biophysical characterization of natural polyreactivity in antibodies.抗体天然多反应性的生化和生物物理特征分析。
Cell Rep. 2023 Oct 31;42(10):113190. doi: 10.1016/j.celrep.2023.113190. Epub 2023 Oct 5.
3
Methods for Posttranslational Induction of Polyreactivity of Antibodies.抗体多反应性的翻译后诱导方法。
Methods Mol Biol. 2017;1643:135-145. doi: 10.1007/978-1-4939-7180-0_10.
4
Relationship between natural and heme-mediated antibody polyreactivity.天然抗体与血红素介导的抗体多反应性之间的关系。
Biochem Biophys Res Commun. 2016 Mar 25;472(1):281-6. doi: 10.1016/j.bbrc.2016.02.112. Epub 2016 Feb 27.
5
Polyreactive Antibodies in Anti-HIV-1 Responses.抗 HIV-1 反应中的多反应性抗体。
Curr Mol Med. 2018;18(2):126-133. doi: 10.2174/1566524018666180720165406.
6
Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.来自HIV-1感染的大量重组人抗体中多反应性的决定因素。
J Immunol. 1996 Jul 15;157(2):739-49.
7
Polyreactive antibodies in adaptive immune responses to viruses.适应性免疫反应中针对病毒的多反应性抗体。
Cell Mol Life Sci. 2012 May;69(9):1435-45. doi: 10.1007/s00018-011-0872-6. Epub 2011 Nov 2.
8
Prediction of polyreactive and nonspecific single-chain fragment variables through structural biochemical features and protein language-based descriptors.通过结构生化特征和基于蛋白质语言的描述符预测多反应性和非特异性单链片段变量。
BMC Bioinformatics. 2022 Dec 5;23(1):520. doi: 10.1186/s12859-022-05010-4.
9
Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping.基于热点残基嫁接和 CDR 环交换的 Keap1 结合抗体表位特异性的计算设计。
Sci Rep. 2017 Jan 27;7:41306. doi: 10.1038/srep41306.
10
Molecular determinants of polyreactive antibody binding: HCDR3 and cyclic peptides.多反应性抗体结合的分子决定因素:重链互补决定区3和环肽
Clin Exp Immunol. 2000 Jan;119(1):69-76. doi: 10.1046/j.1365-2249.2000.01096.x.

引用本文的文献

1
A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, .来自莱姆病螺旋体的外表面蛋白C(OspC)的精细人线性B细胞表位图谱
Pathog Immun. 2025 Feb 14;10(1):159-186. doi: 10.20411/pai.v10i1.756. eCollection 2024.
2
Simulation of adaptive immune receptors and repertoires with complex immune information to guide the development and benchmarking of AIRR machine learning.利用复杂免疫信息模拟适应性免疫受体和库,以指导适应性免疫受体库(AIRR)机器学习的开发和基准测试。
Nucleic Acids Res. 2025 Jan 24;53(3). doi: 10.1093/nar/gkaf025.
3
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers.

本文引用的文献

1
SciPy 1.0: fundamental algorithms for scientific computing in Python.SciPy 1.0:Python 中的科学计算基础算法。
Nat Methods. 2020 Mar;17(3):261-272. doi: 10.1038/s41592-019-0686-2. Epub 2020 Feb 3.
2
An Ancient, MHC-Linked, Nonclassical Class I Lineage in Cartilaginous Fish.软骨鱼类中的一个古老的 MHC 连锁的非经典 I 类基因家族。
J Immunol. 2020 Feb 15;204(4):892-902. doi: 10.4049/jimmunol.1901025. Epub 2020 Jan 13.
3
An MPER antibody neutralizes HIV-1 using germline features shared among donors.一种 MPER 抗体利用供体之间共享的种系特征来中和 HIV-1。
三种癌症中肿瘤内和外周B细胞受体库的系统评估
Elife. 2025 Jan 20;13:RP89506. doi: 10.7554/eLife.89506.
4
Learning antibody sequence constraints from allelic inclusion.从等位基因包含中学习抗体序列约束条件。
bioRxiv. 2024 Oct 25:2024.10.22.619760. doi: 10.1101/2024.10.22.619760.
5
Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions.人类抗体的多反应性主要由重链互补决定区决定。
Cell Rep. 2024 Oct 22;43(10):114801. doi: 10.1016/j.celrep.2024.114801. Epub 2024 Oct 10.
6
Developability considerations for bispecific and multispecific antibodies.双特异性和多特异性抗体的可开发性考虑因素。
MAbs. 2024 Jan-Dec;16(1):2394229. doi: 10.1080/19420862.2024.2394229. Epub 2024 Aug 27.
7
Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies.蛋白质语言模型能够预测单特异性、双特异性和仅重链抗体的多反应性。
Antib Ther. 2024 May 30;7(3):199-208. doi: 10.1093/abt/tbae012. eCollection 2024 Jul.
8
Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries.针对 SARS-CoV-2 RBD 的单域抗体的噬菌体筛选:通用和聚焦合成文库的两阶段筛选。
BMC Infect Dis. 2024 Feb 13;24(1):199. doi: 10.1186/s12879-024-09022-8.
9
Accelerating therapeutic protein design with computational approaches toward the clinical stage.利用计算方法加速治疗性蛋白质设计迈向临床阶段。
Comput Struct Biotechnol J. 2023 Apr 29;21:2909-2926. doi: 10.1016/j.csbj.2023.04.027. eCollection 2023.
10
Polyreactivity of antibodies from different B-cell subpopulations is determined by distinct sequence patterns of variable region.不同 B 细胞亚群的抗体的多反应性由可变区的不同序列模式决定。
Front Immunol. 2023 Nov 23;14:1266668. doi: 10.3389/fimmu.2023.1266668. eCollection 2023.
Nat Commun. 2019 Nov 26;10(1):5389. doi: 10.1038/s41467-019-12973-1.
4
Multiple roles for HIV broadly neutralizing antibodies.HIV 广谱中和抗体的多种作用。
Sci Transl Med. 2019 Oct 30;11(516). doi: 10.1126/scitranslmed.aaz2686.
5
Database resources of the National Center for Biotechnology Information.国家生物技术信息中心数据库资源。
Nucleic Acids Res. 2020 Jan 8;48(D1):D9-D16. doi: 10.1093/nar/gkz899.
6
Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies.可变区序列特征决定治疗性抗体的理化性质和多反应性。
Mol Immunol. 2019 Aug;112:338-346. doi: 10.1016/j.molimm.2019.06.012. Epub 2019 Jun 26.
7
DaReUS-Loop: a web server to model multiple loops in homology models.DaReUS-Loop:一个用于对同源模型中的多个环建模的网络服务器。
Nucleic Acids Res. 2019 Jul 2;47(W1):W423-W428. doi: 10.1093/nar/gkz403.
8
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.VRC01 广泛中和抗体在急性 HIV 成人患者中的安全性和疗效(RV397):一项 2 期、随机、双盲、安慰剂对照试验。
Lancet HIV. 2019 May;6(5):e297-e306. doi: 10.1016/S2352-3018(19)30053-0. Epub 2019 Apr 15.
9
HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells.肠道多反应性和交叉反应性 B 细胞对 HIV-1 包膜的识别。
Cell Rep. 2019 Apr 9;27(2):572-585.e7. doi: 10.1016/j.celrep.2019.03.032.
10
V1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design.V1-69 广谱中和抗体:遗传学、结构及其对合理疫苗设计的意义。
Curr Opin Virol. 2019 Feb;34:149-159. doi: 10.1016/j.coviro.2019.02.004. Epub 2019 Mar 16.